Scotia Capital’s Biogen BIIB Stock Holding History

Scotia Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,274	Closed	-$1.15M	–	918
2026 Q1	$1.15M	Buy	+6,274	New	+$1.16M	﹤0.01%	551
2023 Q1	–	Sell	-3,516	Closed	-$974K	–	789
2022 Q4	$974K	Buy	+3,516	New	+$993K	0.01%	454
2018 Q1	–	Sell	-9,953	Closed	-$3.17M	–	704
2017 Q4	$3.17M	Buy	9,953 +1,001	+11%	+$321K	0.04%	223
2017 Q3	$2.8M	Buy	+8,952	New	+$2.65M	0.04%	235
2014 Q2	–	Sell	-936	Closed	-$286K	–	575
2014 Q1	$286K	Buy	+936	New	+$297K	0.01%	484

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Scotia Capital's BIIB Position: Q2 2026 in Review

Scotia Capital sold out of Biogen (BIIB) in Q2 2026, closing a stake of 6,274 shares — an estimated $1.15M sold.

Scotia Capital first reported a position in BIIB in Q1 2014 and held it in 5 quarters. The position peaked at $3.17M in Q4 2017. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Scotia Capital reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
Scotia Capital sold 6,274 Biogen shares in Q2 2026, an estimated $1.15M.
Scotia Capital first reported a position in Biogen in Q1 2014 and held it in 5 quarters.
Scotia Capital's Biogen position peaked at $3.17M in Q4 2017.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.